You have 9 free searches left this month | for more free features.

City

Atlanta (1)

Aurora (1)

Fairport (1)

Houston (1)

Condition

Head and Neck Carcinoma of Unknown Primary (1)

Locally Advanced Head and Neck Squamous Cell Carcinoma (1)

Locally Advanced Hypopharyngeal Squamous Cell Carcinoma (1)

Locally Advanced Laryngeal Squamous Cell Carcinoma (1)

Locally Advanced Nasopharyngeal Squamous Cell Carcinoma (1)

Locally Advanced Oropharyngeal Squamous Cell Carcinoma (1)

Relapsed/Refractory Peripheral T-cell Lymphoma (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

early phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Astex Pharmaceuticals, Inc. (1)

Emory University (1)

Collaborator

Astex Pharmaceuticals, Inc. (1)

Intervention

tolinapant (2)

decitabine + cedazuridine (1)

radiation therapy (1)

Study Documents

Intervention Type

drug (2)

radiation (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

tolinapant

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Relapsed/Refractory Peripheral T-cell Lymphoma Trial in Fairport (Tolinapant, Decitabine + Cedazuridine)

Recruiting

Relapsed/Refractory Peripheral T-cell Lymphoma

Tolinapant
Decitabine + Cedazuridine

Aurora, Colorado
+2 more

Jan 3, 2023

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting

Head and Neck Carcinoma of Unknown Primary
+5 more

Tolinapant
Radiation Therapy

Atlanta, Georgia

Emory University/Winship Cancer Institute

Feb 17, 2022